Business
Time to debunk anti-vaxxer myths: CSL CEO – The Australian Financial Review
Demand for CSL’s core plasma products and surging government orders for flu vaccines has resulted in the biotech giant lifting the bottom end of its 2021 profit…
“We don’t have the ability to just turn on a dime and start making more flu vaccines … when we start the manufacturing process it’s pretty well done… and to turn and make more is very difficult late in the season, but we’ve had good yield
Continue Reading
-
General19 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News16 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General8 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General18 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba